ArticleJournal of bone oncology2019

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model.

Chiara Spadazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.